Doximity
(NYSE) DOCS
Doximity Financials at a Glance
Market Cap
$3.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$644.86M
Net Income (TTM)
$196.05M
EPS (TTM)
$0.98
P/E Ratio
22.19
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$21.77
Volume
60,170
Open
$22.46
Price
$21.77
Volume
60,170
Open
$22.46
Previous Close
$21.77
Daily Range
$21.58 - $22.46
52-Week Range
$17.15 - $76.51
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$21.77
Volume
60,170
Open
$22.46
Previous Close
$21.77
Daily Range
$21.58 - $22.46
52-Week Range
$17.15 - $76.51
Estimated Earnings Date
Aug 6, 2026
DOCS News
DOCS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Doximity
Industry
Health Care Technology
Sector
Health CareEmployees
880
CEO
Jeffrey A. Tangney, MBA
Website
www.doximity.comHeadquarters
San Francisco, CA 94107, US
DOCS Financials
Key Financial Metrics (TTM)
Gross Margin
89.09%
Operating Margin
33.33%
Net Income Margin
30.40%
Return on Equity
19.36%
Return on Capital
22.36%
Return on Assets
17.45%
Earnings Yield
4.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
182.87M
Volume
60.17K
Avg. Volume
4.10M
Financials (TTM)
Gross Profit
$574.54M
Operating Income
$214.92M
EBITDA
$266.09M
Operating Cash Flow
$326.46M
Capital Expenditure
-$8.96M
Free Cash Flow
$317.50M
Cash & ST Invst.
$748.60M
Total Debt
$10.19M
Doximity Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$145.37M
+5.1%
Gross Profit
$125.97M
+1.7%
Gross Margin
86.65%
N/A
Market Cap
$3.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.81M
N/A
Employees
827
N/A
Net Income
$19.11M
-69.4%
EBITDA
$36.25M
-40.8%
Quarterly Fundamentals
Total Cash
$748.60M
-18.2%
Total Debt
$10.19M
-17.8%
Accounts Receivable
$144.78M
+12.8%
Inventory
$0.00
N/A
Long Term Debt
$8.07M
-20.7%
Short Term Debt
$2.11M
-4.6%
Return on Assets
17.45%
N/A
Return on Invested Capital
22.19%
N/A
Free Cash Flow
$107.27M
+10.6%
Operating Cash Flow
$109.52M
+11.2%